Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Wallace

Sports Medicine Naples, FL Doctor of Osteopathy

NPI 1518118462 CMS profile 662592

1250 Pine Ridge Rd, Suite 203, Naples, FL 34108

Open in the dashboard

General payments

$50,940

272 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brian Wallace of Naples, FL is reported in the CMS Open Payments database as having received $50,940 across 272 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,681 23
2024 General $7,070 44
2023 General $9,038 55
2022 General $10,395 52
2021 General $6,655 43
2020 General $3,901 16
2019 General $7,201 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Wallace
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Brian Wallace were reported at $6,681. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Brian Wallace Sports Medicine median Middle half National median
2019 $7,201 $1,176 $199–$4,249 $163
2020 $3,901 $708 $96–$2,890 $114
2021 $6,655 $1,213 $152–$3,994 $132
2022 $10,395 $1,230 $159–$3,998 $149
2023 $9,038 $584 $146–$2,836 $160
2024 $7,070 $628 $163–$3,168 $164
2025 $6,681 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $46,553 266 payments
  2. Medical Device Business Services, Inc. $4,050 1 payment
  3. Stryker Corporation $233 1 payment
  4. Smith+Nephew, Inc. $70 2 payments
  5. Zimmer Biomet Holdings, Inc. $28 1 payment
  6. Kerecis Limited $8 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $34,104 75 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,690 5 payments
  3. Education $5,033 5 payments
  4. Food and Beverage $4,202 166 payments
  5. Travel and Lodging $1,912 21 payments
Products named General payments · program years 2019–2025
  1. LCP PLATES & SCREWS $4,050 1 payment
  2. VA-LCP PLATES & SCREWS $4,050 1 payment
  3. INSTRUMENTS $4,050 1 payment
  4. CANNULATED SCREWS $4,050 1 payment
  5. DISTAL EXTREMITIES IMPLANTS TRAUMA CLAVICLE FRACTURE $550 3 payments
  6. Arthrex $460 1 payment
  7. DISTAL EXTREMITIES IMPLANTS SOFT TISSUE FIBERTAK $275 1 payment
  8. TRIATHLON $233 1 payment
  9. ARTHROPLASTY IMPLANTS REVERS TOTAL SHOULDER MODULAR GLENOID SYSTEMS $40 1 payment
  10. 660HD Image Management System $35 1 payment
  11. Other $171 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

371

Median for Orthopedic Surgery: 203

Drug cost

$3,066

Median for Orthopedic Surgery: $1,433

Branded share of claims

60.9%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 208 $2,311
Methylprednisolone Generic 36 $225
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 18 $152
Tramadol Hcl Generic 46 $127
Cyclobenzaprine Hcl Generic 17 $92
Cephalexin Generic 17 $89
Doxycycline Hyclate Generic 12 $59
Meloxicam Generic 17 $12

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$263,922

Of which drugs: $6,041

Medicare patients

505

Average age 76

Services billed

8,154

282 women, 223 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 72%
Ischemic heart disease 41%
Depression 24%
Chronic kidney disease 22%
Diabetes 21%
Atrial fibrillation 21%
Osteoporosis 21%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 275 3,552 $2,711

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

272 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record